Form 4: Ultralife Corp CEO Michael Manna Acquires 1,500 Shares
SEC Form 4 Filing
Ultralife Corp's CEO, Michael Manna, purchased 1,500 shares of common stock at $7.245 per share on November 21, 2024.
Summary
- Michael Manna, the President and CEO of Ultralife Corp, acquired 1,500 shares of the company's common stock on November 21, 2024.
- The purchase price was $7.245 per share.
- Following this transaction, Mr. Manna directly owns 19,874 shares of Ultralife Corp.
Sentiment
Score: 7
Explanation: The purchase of shares by the CEO is generally a positive sign, suggesting confidence in the company's future. However, it's a single transaction and doesn't provide a comprehensive view of the company's overall health.
Positives
- The CEO's purchase of shares can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
This is a standard SEC Form 4 filing, which is common for corporate insiders who trade their company's stock. It provides transparency into the trading activities of key personnel.
Comparison to Industry Standards
- Form 4 filings are a standard practice for publicly traded companies in the United States, ensuring transparency of insider trading activities.
- The purchase of shares by a CEO is a common occurrence and is often viewed as a positive sign of confidence in the company's future.
Stakeholder Impact
- The purchase of shares by the CEO may positively influence investor sentiment.
Key Dates
| Date | Description |
|---|---|
| 11/21/2024 | Date of the stock purchase by Michael Manna. |
Keywords
Ultralife Corp, Michael Manna, insider trading, stock purchase, common stock, ULBI, CEO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.